Setmelanotide
DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway
Rhythm · Phase 2 · Completed · Enrollment 164
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Stage 1: Setmelanotide (Open-Label) | 75 participants | 41 participants | 22 participants | n/r | 0 |
| Stage 2: Setmelanotide (Double-Blind) | 4 participants | 3 participants | 2 participants | n/r | 0 |
| Stage 2: Placebo (Double-Blind) | 0 participants | 0 participants | 0 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.